242 related articles for article (PubMed ID: 2029092)
1. The epidermal melanin unit in the pathophysiology of malignant melanoma.
Jimbow K; Salopek TG; Dixon WT; Searles GE; Yamada K
Am J Dermatopathol; 1991 Apr; 13(2):179-88. PubMed ID: 2029092
[TBL] [Abstract][Full Text] [Related]
2. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines.
Rhodes AR; Melski JW; Sober AJ; Harrist TJ; Mihm MC; Fitzpatrick TB
J Invest Dermatol; 1983 May; 80(5):452-9. PubMed ID: 6341476
[TBL] [Abstract][Full Text] [Related]
3. Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2.
Maeda K; Maeda K; Jimbow K
J Invest Dermatol; 1988 Sep; 91(3):247-50. PubMed ID: 3411143
[TBL] [Abstract][Full Text] [Related]
4. Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation.
Rhodes AR; Seki Y; Fitzpatrick TB; Stern RS
Cancer; 1988 Jan; 61(2):358-69. PubMed ID: 3334971
[TBL] [Abstract][Full Text] [Related]
5. Melanin pigments and melanosomal proteins as differentiation markers unique to normal and neoplastic melanocytes.
Jimbow K; Lee SK; King MG; Hara H; Chen H; Dakour J; Marusyk H
J Invest Dermatol; 1993 Mar; 100(3):259S-268S. PubMed ID: 8440900
[TBL] [Abstract][Full Text] [Related]
6. Dysplastic melanocytic nevi contain high levels of pheomelanin: quantitative comparison of pheomelanin/eumelanin levels between normal skin, common nevi, and dysplastic nevi.
Salopek TG; Yamada K; Ito S; Jimbow K
Pigment Cell Res; 1991 Oct; 4(4):172-9. PubMed ID: 1816549
[TBL] [Abstract][Full Text] [Related]
7. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.
Jimbow K; Horikoshi T; Takahashi H; Akutsu Y; Maeda K
J Invest Dermatol; 1989 May; 92(5 Suppl):304S-309S. PubMed ID: 2715663
[TBL] [Abstract][Full Text] [Related]
8. The silver locus product (Silv/gp100/Pmel17) as a new tool for the analysis of melanosome transfer in human melanocyte-keratinocyte co-culture.
Singh SK; Nizard C; Kurfurst R; Bonte F; Schnebert S; Tobin DJ
Exp Dermatol; 2008 May; 17(5):418-26. PubMed ID: 18331332
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.
Hida T; Kamiya T; Kawakami A; Ogino J; Sohma H; Uhara H; Jimbow K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854423
[TBL] [Abstract][Full Text] [Related]
10. The biology of melanocytes.
Sulaimon SS; Kitchell BE
Vet Dermatol; 2003 Apr; 14(2):57-65. PubMed ID: 12662262
[TBL] [Abstract][Full Text] [Related]
11. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
[TBL] [Abstract][Full Text] [Related]
12. From Melanocytes to Melanoma Cells: Characterization of the Malignant Transformation by Four Distinctly Different Melanin Fluorescence Spectra (Review).
Leupold D; Pfeifer L; Hofmann M; Forschner A; Wessler G; Haenssle H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067690
[TBL] [Abstract][Full Text] [Related]
13. Specification and use of a mouse monoclonal antibody raised against melanosomes for the histopathologic diagnosis of amelanotic malignant melanoma.
Maeda K; Maeda K; Jimbow K
Cancer; 1988 Sep; 62(5):926-34. PubMed ID: 3044572
[TBL] [Abstract][Full Text] [Related]
14. Fine structural characterization of melanosomes in dysplastic nevi.
Takahashi H; Horikoshi T; Jimbow K
Cancer; 1985 Jul; 56(1):111-23. PubMed ID: 4005780
[TBL] [Abstract][Full Text] [Related]
15. The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytes.
Leupold D; Scholz M; Stankovic G; Reda J; Buder S; Eichhorn R; Wessler G; Stücker M; Hoffmann K; Bauer J; Garbe C
Pigment Cell Melanoma Res; 2011 Jun; 24(3):438-45. PubMed ID: 21457482
[TBL] [Abstract][Full Text] [Related]
16. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.
Maeda K; Jimbow K
Cancer; 1987 Feb; 59(3):415-23. PubMed ID: 3539311
[TBL] [Abstract][Full Text] [Related]
17. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes.
Hauser JE; Kadekaro AL; Kavanagh RJ; Wakamatsu K; Terzieva S; Schwemberger S; Babcock G; Rao MB; Ito S; Abdel-Malek ZA
Pigment Cell Res; 2006 Aug; 19(4):303-14. PubMed ID: 16827749
[TBL] [Abstract][Full Text] [Related]
18. The melanocyte and the epidermal melanin unit: an expanded concept.
Nordlund JJ
Dermatol Clin; 2007 Jul; 25(3):271-81, vii. PubMed ID: 17662893
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Kopera D; Hohenleutner U; Stolz W; Landthaler M
Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
[TBL] [Abstract][Full Text] [Related]
20. Melanin's Journey from Melanocytes to Keratinocytes: Uncovering the Molecular Mechanisms of Melanin Transfer and Processing.
Bento-Lopes L; Cabaço LC; Charneca J; Neto MV; Seabra MC; Barral DC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
